Short Interest in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Declines By 31.2%

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) saw a large decline in short interest during the month of January. As of January 30th, there was short interest totaling 357,811 shares, a decline of 31.2% from the January 15th total of 520,263 shares. Currently, 3.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 118,750 shares, the days-to-cover ratio is presently 3.0 days. Based on an average daily trading volume, of 118,750 shares, the days-to-cover ratio is presently 3.0 days. Currently, 3.9% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ZEPP. Fundamental Research set a $64.37 price objective on shares of Zepp Health and gave the stock a “buy” rating in a report on Tuesday, November 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Zepp Health in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $64.37.

Zepp Health Stock Down 3.4%

ZEPP traded down $0.83 during trading on Friday, hitting $23.50. 172,367 shares of the stock traded hands, compared to its average volume of 149,864. Zepp Health has a 12-month low of $2.13 and a 12-month high of $61.85. The company has a current ratio of 1.09, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. The firm has a 50-day moving average of $24.95 and a 200 day moving average of $33.87.

Zepp Health (NYSE:ZEPP) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.04) EPS for the quarter. The firm had revenue of $75.79 million for the quarter. Zepp Health had a negative net margin of 28.28% and a negative return on equity of 21.45%.

Institutional Trading of Zepp Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ZEPP. Ariose Capital Management Ltd bought a new position in Zepp Health in the 3rd quarter worth $1,269,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Zepp Health during the third quarter valued at about $1,895,000. Lighthouse Investment Partners LLC bought a new position in Zepp Health in the third quarter worth about $2,070,000. Millennium Management LLC purchased a new stake in Zepp Health in the third quarter worth about $11,265,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Zepp Health during the 3rd quarter valued at approximately $43,000. Hedge funds and other institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.